quinaprilat has been researched along with enalaprilat anhydrous in 12 studies
| Studies (quinaprilat) | Trials (quinaprilat) | Recent Studies (post-2010) (quinaprilat) | Studies (enalaprilat anhydrous) | Trials (enalaprilat anhydrous) | Recent Studies (post-2010) (enalaprilat anhydrous) |
|---|---|---|---|---|---|
| 92 | 23 | 4 | 846 | 109 | 76 |
| Protein | Taxonomy | quinaprilat (IC50) | enalaprilat anhydrous (IC50) |
|---|---|---|---|
| Angiotensin-converting enzyme | Mus musculus (house mouse) | 0.0115 | |
| Angiotensin-converting enzyme | Homo sapiens (human) | 0.2405 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.0054 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0012 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 0.0036 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 0.0024 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 4 (33.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Codding, PW; Hausin, RJ | 1 |
| Cohen, D; Essenburg, AD; Kaplan, HR; Roark, WH; Tinney, FJ | 1 |
| Blankley, CJ; Cohen, DM; Essenburg, AD; Fleming, RW; Hinkley, JM; Hoefle, ML; Holmes, A; Klutchko, S; Nordin, I; Werner, AE | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bree, F; Chevillard, C; Corvol, P; Hamon, G; Jouquey, S; Mathieu, MN; Stepniewski, JP; Tillement, JP | 1 |
| Bumpus, FM; Husain, A; Kinoshita, A; Urata, H | 1 |
| Abiko, Y; Hara, A; Hashizume, H; Ma, H; Yazawa, K | 1 |
| de Haan, CH; de Leeuw, PW; Fuss-Lejeune, MJ; Houben, AJ; Kroon, AA | 1 |
| Bao, Y; Bernard, SA; Colton, T; Lazar, HL; Rivers, S | 1 |
| Backman, JT; Holmberg, MT; Launiainen, T; Neuvonen, PJ; Niemi, M; Tarkiainen, EK; Tornio, A | 1 |
2 trial(s) available for quinaprilat and enalaprilat anhydrous
| Article | Year |
|---|---|
Quinaprilat-induced vasodilatation in forearm vasculature of patients with essential hypertension: comparison with enalaprilat.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Enalaprilat; Forearm; Heart Rate; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Peptidyl-Dipeptidase A; Regional Blood Flow; Tetrahydroisoquinolines; Vasodilation | 2000 |
Effect of carboxylesterase 1 c.428G > A single nucleotide variation on the pharmacokinetics of quinapril and enalapril.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Carboxylic Ester Hydrolases; Cross-Over Studies; Enalapril; Enalaprilat; Female; Genotype; Healthy Volunteers; Heart Rate; Humans; Male; Polymorphism, Single Nucleotide; Quinapril; Tetrahydroisoquinolines; Young Adult | 2015 |
10 other study(ies) available for quinaprilat and enalaprilat anhydrous
| Article | Year |
|---|---|
Molecular and crystal structures of MDL27,467A hydrochloride and quinapril hydrochloride, two ester derivatives of potent angiotensin converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Crystallography; Isoquinolines; Pyridones; Quinapril; Tetrahydroisoquinolines | 1991 |
Synthesis and biological activity of modified peptide inhibitors of angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Chemical Phenomena; Chemistry; Dipeptides; Enalapril; Guinea Pigs; Hypertension, Renal; Indoles; Isoquinolines; Quinapril; Rats; Structure-Activity Relationship; Tetrahydroisoquinolines | 1985 |
Synthesis of novel angiotensin converting enzyme inhibitor quinapril and related compounds. A divergence of structure-activity relationships for non-sulfhydryl and sulfhydryl types.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Isoquinolines; Male; Molecular Conformation; Quinapril; Rats; Rats, Inbred Strains; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrahydroisoquinolines | 1986 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Compared properties of trandolapril, enalapril, and their diacid metabolites.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Enalapril; Enalaprilat; Indoles; Isoquinolines; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Solubility; Tetrahydroisoquinolines | 1994 |
Measurement of angiotensin I converting enzyme inhibition in the heart.
Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Captopril; Cricetinae; Dipeptides; Enalaprilat; Humans; Isoquinolines; Lisinopril; Male; Mesocricetus; Papillary Muscles; Tetrahydroisoquinolines | 1993 |
Protective effect of quinaprilat, an active metabolite of quinapril, on Ca2+-overload induced by lysophosphatidylcholine in isolated rat cardiomyocytes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Calcium; Cell Size; Creatine Kinase; Enalapril; Enalaprilat; Isoquinolines; Lysophosphatidylcholines; Male; Micelles; Myocardium; Propranolol; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Vasodilator Agents | 1999 |
High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Enalaprilat; Endothelium, Vascular; Infusions, Intravenous; Isoquinolines; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Necrosis; Swine; Tetrahydroisoquinolines | 2001 |